In the dynamic landscape of pharmaceuticals and healthcare, staying updated on the latest developments in Orphan Drug Designation is of…
In the dynamic landscape of pharmaceuticals and healthcare, staying updated on the latest developments in Orphan Drug Designation is of…
On April 18, 2023, Madrigal Pharmaceuticals, a clinical-stage biopharmaceutical company, announced that its drug candidate resmetirom has received the Breakthrough…
On April 21, 2023, XORTX Therapeutics Inc., a clinical-stage biopharmaceutical company, announced that it has received the Orphan Drug Designation…
On April 17, 2023, the combination of botensilimab (AGEN1181) and balstilimab (AGEN2034) has been granted fast-track designation by the FDA…
On April 21, 2023, Medtronic plc (NYSE: MDT), a global leader in medical technology, announced FDA approval of its MiniMed…
On April 20, 2023, LuxCreo, a leading 3D printing specialist in clear dental appliances, announced an FDA Class II 510(k)…